![Gavin Malenfant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Gavin T.
Malenfant is the founder of GMalenfant Consulting LLC, founded in 2018.
Former positions include Head-Operations & Vice President at Sarepta Therapeutics, Inc. from 2015 to 2016, Head-Operations at Genzyme Corp., Head-Corporate Operations & Program Management at Akebia Therapeutics, Inc. from 2016 to 2018, and Chief Operating Officer at ProMIS Neurosciences, Inc. from 2021 to 2025.
Education includes an undergraduate degree from the University of Massachusetts Boston.
Anciens postes connus de Gavin Malenfant
| Sociétés | Poste | Fin |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Directeur des opérations | 14/02/2025 |
GMalenfant Consulting LLC | Fondateur | 01/10/2021 |
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2018 |
| SAREPTA THERAPEUTICS, INC. | Directeur des opérations | 01/01/2016 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Directeur des opérations | - |
Formation de Gavin Malenfant
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
University of Massachusetts Boston
 University of Massachusetts Boston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GMalenfant Consulting LLC |
